Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Kaye

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Obstetrics and Gynecology|December 24, 2008
Postmenopausal estrogen-containing hormone therapy and the risk of breast cancerSusan S Jick, Katrina W Hagberg, James A Kaye, et al.
Oncotargets and Therapy|October 31, 2012
Review of meta-analyses evaluating surrogate endpoints for overall survival in oncologyBeth Sherrill, James A Kaye, Rickard Sandin, et al.
Contraception|December 17, 2009
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolismSusan S Jick, Katrina W Hagberg, Rohini K Hernandez, et al.
Breast Cancer Research and Treatment|September 21, 2004
Tamoxifen and cataracts: a null associationBrian D Bradbury, Timothy L Lash, James A Kaye, et al.
Cancer|February 16, 2005
Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed anginaBrian D Bradbury, Timothy L Lash, James A Kaye, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 2, 2020
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple MyelomaJan Bassali, Ian Gopal Gould, James A Kaye, et al.
Future Oncology (London, England)|September 28, 2021
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusionMarco Boeri, Anna G Purdum, Jessie Sutphin, et al.
International Journal of Hematology|February 22, 2012
Patient characteristics and treatment patterns in chronic myeloid leukemia: evidence from a multi-country retrospective medical record chart review studyDebanjali Mitra, Peter C Trask, Shrividya Iyer, et al.
International Journal of Hematology|March 31, 2012
Patterns and prognostic indicators of response to CML treatment in a multi-country medical record review studyPeter C Trask, Debanjali Mitra, Shrividya Iyer, et al.
Clinical Therapeutics|April 25, 2015
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective StudyEmily Nash Smyth, Bela Bapat, Daniel E Ball, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Obstetrics and Gynecology|December 24, 2008
Postmenopausal estrogen-containing hormone therapy and the risk of breast cancerSusan S Jick, Katrina W Hagberg, James A Kaye, et al.
Oncotargets and Therapy|October 31, 2012
Review of meta-analyses evaluating surrogate endpoints for overall survival in oncologyBeth Sherrill, James A Kaye, Rickard Sandin, et al.
Contraception|December 17, 2009
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolismSusan S Jick, Katrina W Hagberg, Rohini K Hernandez, et al.
Breast Cancer Research and Treatment|September 21, 2004
Tamoxifen and cataracts: a null associationBrian D Bradbury, Timothy L Lash, James A Kaye, et al.
Cancer|February 16, 2005
Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed anginaBrian D Bradbury, Timothy L Lash, James A Kaye, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 2, 2020
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple MyelomaJan Bassali, Ian Gopal Gould, James A Kaye, et al.
Future Oncology (London, England)|September 28, 2021
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusionMarco Boeri, Anna G Purdum, Jessie Sutphin, et al.
International Journal of Hematology|February 22, 2012
Patient characteristics and treatment patterns in chronic myeloid leukemia: evidence from a multi-country retrospective medical record chart review studyDebanjali Mitra, Peter C Trask, Shrividya Iyer, et al.
International Journal of Hematology|March 31, 2012
Patterns and prognostic indicators of response to CML treatment in a multi-country medical record review studyPeter C Trask, Debanjali Mitra, Shrividya Iyer, et al.
Clinical Therapeutics|April 25, 2015
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective StudyEmily Nash Smyth, Bela Bapat, Daniel E Ball, et al.
Pageof 11